These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9083606)

  • 41. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome.
    Orth M; Kirby R; Richardson MP; Snijders AH; Rothwell JC; Trimble MR; Robertson MM; Münchau A
    Clin Neurophysiol; 2005 Apr; 116(4):764-8. PubMed ID: 15792884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mother-child agreement on behavioral ratings in Tourette syndrome: a controlled study.
    Termine C; Luoni C; Selvini C; Bandera V; Balottin U; Eddy CM; Cavanna AE
    J Child Neurol; 2014 Jan; 29(1):79-83. PubMed ID: 23307882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gilles de la Tourette syndrome mimicking an eating disorder].
    Van den Eynde F; Sentürk V; Naudts K
    Turk Psikiyatri Derg; 2007; 18(4):375-8. PubMed ID: 18066728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tourette syndrome.
    Licamele WL; Goldberg RL
    Am Fam Physician; 1988 Apr; 37(4):115-9. PubMed ID: 3162786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Disorders associated with the Gilles de la Tourette syndrome].
    Muñoz-Yunta JA; Freixas A; Valls-Santasusana A; Gómez C
    Rev Neurol; 1999 Feb; 28 Suppl 2():S156-9. PubMed ID: 10778506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
    Gilbert DL; Bansal AS; Sethuraman G; Sallee FR; Zhang J; Lipps T; Wassermann EM
    Mov Disord; 2004 Apr; 19(4):416-25. PubMed ID: 15077239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapeutic effect of inosine in Tourette syndrome and its possible mechanism of action].
    Cheng Y; Jiang DH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Apr; 23(2):90-3, 126-7. PubMed ID: 2390879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fragile X syndrome associated with tic disorders.
    Schneider SA; Robertson MM; Rizzo R; Turk J; Bhatia KP; Orth M
    Mov Disord; 2008 Jun; 23(8):1108-12. PubMed ID: 18383111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anesthetic management for cesarean delivery in a woman with Gilles de la Tourette's syndrome.
    Sener EB; Kocamanoglu S; Ustun E; Tur A
    Int J Obstet Anesth; 2006 Apr; 15(2):163-5. PubMed ID: 16434179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.
    Egolf A; Coffey BJ
    Drugs Today (Barc); 2014 Feb; 50(2):159-79. PubMed ID: 24619591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tics of Tourette: important points in management.
    Daniel AE; Chapel JL
    J Dev Behav Pediatr; 1981 Dec; 2(4):166-7. PubMed ID: 6947982
    [No Abstract]   [Full Text] [Related]  

  • 54. Behavioral problems and severity of tics.
    Rosenberg LA; Brown J; Singer HS
    J Clin Psychol; 1995 Nov; 51(6):760-7. PubMed ID: 8778123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():433-6. PubMed ID: 6959521
    [No Abstract]   [Full Text] [Related]  

  • 56. "Tardive" Tourette syndrome in relation to long-term neuroleptic treatment of multiple tics.
    Fog R; Pakkenberg H; Regeur L; Pakkenberg B
    Adv Neurol; 1982; 35():419-21. PubMed ID: 6128887
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe motor and vocal tics controlled with Sativex®.
    Trainor D; Evans L; Bird R
    Australas Psychiatry; 2016 Dec; 24(6):541-544. PubMed ID: 27558217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E; Shapiro AK
    Adv Neurol; 1982; 35():413. PubMed ID: 6959518
    [No Abstract]   [Full Text] [Related]  

  • 59. The potential role of haloperidol in the treatment of trichotillomania.
    Van Ameringen M; Mancini C; Oakman JM; Farvolden P
    J Affect Disord; 1999 Dec; 56(2-3):219-26. PubMed ID: 10701481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral effects of haloperidol in young Tourette syndrome patients.
    Bogomolny A; Erenberg G; Rothner AD
    Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.